ACAD
39.28
+0.06
+0.15%
AEMD
3.776
+0.016
+0.4309%
APRI
3.206
+0.316
+10.9446%
ARNA
1.49
0.00
0.00%
ATEC
2.91
+0.02
+0.69%
CNAT
5.25
+0.03
+0.57%
CRXM
0.255
+0.033
+14.968%
CYTX
1.85
-0.04
-2.12%
DXCM
81.89
+0.5
+0.61%
GNMK
10.545
+0.045
+0.429%
HALO
12.61
+0.05
+0.40%
ILMN
163.37
+2.07
+1.28%
INNV
0.17
+0.01
+6.92%
INO
6.96
-0.04
-0.57%
ISCO
1.04
-0.04
-3.70%
ISIS
57.56
0.00
0.00%
LGND
105.71
+0.38
+0.36%
LPTN
2.93
0.00
0.00%
MBVX
3.01
+0.44
+17.12%
MEIP
1.74
+0.02
+1.16%
MNOV
6.11
+0.03
+0.49%
MRTX
6.2
+0.2
+3.33%
MSTX
0.13
+0.001
+0.6966%
NBIX
44.05
+0.9
+2.09%
NUVA
74.22
+0.25
+0.34%
ONCS
1.4
+0.02
+1.45%
ONVO
2.97
+0.08
+2.77%
OREX
4.38
-0.3
-6.41%
OTIC
15.55
+0.5
+3.32%
QDEL
20.89
+0.2
+0.97%
RCPT
231.96
0.00
0.00%
RGLS
1.15
-0.05
-4.17%
RMD
72.27
+0.35
+0.49%
SCIE
0.001
+0.00
+32.00000%
SPHS
2.76
-0.03
-1.08%
SRNE
5.55
-0.07
-1.33%
TROV
2.1
+0.05
+2.44%
VICL
2.26
-0.01
-0.44%
VOLC
18
0.00
0.00%
ZGNX
10.2
-0.25
-2.39%
ACAD
39.28
+0.06
+0.15%
AEMD
3.776
+0.016
+0.4309%
APRI
3.206
+0.316
+10.9446%
ARNA
1.49
0.00
0.00%
ATEC
2.91
+0.02
+0.69%
CNAT
5.25
+0.03
+0.57%
CRXM
0.255
+0.033
+14.968%
CYTX
1.85
-0.04
-2.12%
DXCM
81.89
+0.5
+0.61%
GNMK
10.545
+0.045
+0.429%
HALO
12.61
+0.05
+0.40%
ILMN
163.37
+2.07
+1.28%
INNV
0.17
+0.01
+6.92%
INO
6.96
-0.04
-0.57%
ISCO
1.04
-0.04
-3.70%
ISIS
57.56
0.00
0.00%
LGND
105.71
+0.38
+0.36%
LPTN
2.93
0.00
0.00%
MBVX
3.01
+0.44
+17.12%
MEIP
1.74
+0.02
+1.16%
MNOV
6.11
+0.03
+0.49%
MRTX
6.2
+0.2
+3.33%
MSTX
0.13
+0.001
+0.6966%
NBIX
44.05
+0.9
+2.09%
NUVA
74.22
+0.25
+0.34%
ONCS
1.4
+0.02
+1.45%
ONVO
2.97
+0.08
+2.77%
OREX
4.38
-0.3
-6.41%
OTIC
15.55
+0.5
+3.32%
QDEL
20.89
+0.2
+0.97%
RCPT
231.96
0.00
0.00%
RGLS
1.15
-0.05
-4.17%
RMD
72.27
+0.35
+0.49%
SCIE
0.001
+0.00
+32.00000%
SPHS
2.76
-0.03
-1.08%
SRNE
5.55
-0.07
-1.33%
TROV
2.1
+0.05
+2.44%
VICL
2.26
-0.01
-0.44%
VOLC
18
0.00
0.00%
ZGNX
10.2
-0.25
-2.39%
Home » Archive by Category

Syndication

Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing

February 2, 2017 – 12:09 pm

A team of decorated academic chemists in San Diego have been working since 2014 on a biotech startup that aims to find new drugs faster. The company now has a lot of cash in the bank and a well-known…

[[Click headline to continue reading.]]

Sr. Research Associate (Biochemistry) (San Diego)

February 2, 2017 – 11:37 am

ELISA Specialist: -Run assays (mainly ELISA) to meet final requirements of QAU review and release. -Perform assays according to GLP guidelines. -Writing of SOPs and contribution to final written SOPs in the laboratory. -Write final validation reports […

Research Associate – Molecular Biology (La Jolla)

February 2, 2017 – 11:02 am

Inhibrx is clinical stage biologic immunotherapeutic company in La Jolla focused on the treatment of high unmet medical needs in oncology, infectious disease and inflammatory conditions. Inhibrx’s proprietary platforms enable fit-for-function biother […

Infrastructure Manager – Ensunet Technology Group – San Diego, CA

February 2, 2017 – 9:06 am

Ensunet Technology Group provides superior technology professional services for BioTechnology , Healthcare, and Government agencies in the areas of strategic…From Monster – Thu, 02 Feb 2017 17:06:42 GMT – View all San Diego jobs

Life Care Researcher – Ascent Services Group – San Diego, CA

February 2, 2017 – 8:35 am

Ascent Life Sciences, A Division of the Ascent Services Group specializes in nationwide direct hire, contract placement and 3rd party payroll for the…From Ascent Services Group – Thu, 02 Feb 2017 16:35:46 GMT – View all San Diego jobs

Insurer UHC Will Cover Biogen Spine Drug, But With Limits And Proof

February 2, 2017 – 7:25 am

[Updated, 1:57 pm E.T., see below] Another major U.S. health insurer, UnitedHealthCare, has said it would cover the first-ever approved drug for the rare disease spinal muscular atrophy, a closely…

[[Click headline to continue reading.]]

Tenzin Gyatso, His Holiness the 14th Dalai Lama to Speak at UC San Diego Commencement

February 2, 2017 – 7:00 am

The University of California San Diego, one of the top 15 research universities in the world and recognized for its contributions to the public good, in partnership with The Friends of the Dalai Lama Foundation, fo…

Sr. Manager/Associate Director, Quality Assurance – Sorrento Therapeutics – San Diego, CA

February 2, 2017 – 5:04 am

SRNE), is a biotechnology company creating next generation of Antibody Drug Conjugates (ADCs) using our proprietary conjugation technologies and novel drug…From Sorrento Therapeutics – Thu, 02 Feb 2017 13:04:13 GMT – View all San Diego jobs

Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference

February 2, 2017 – 5:00 am

SOUTH SAN FRANCISCO, Calif., Feb. 2, 2017 /PRNewswire/ — Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman of the board, president and chief executive officer, will present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:00 p.m. ET in New York, NY.

The live audio webcast from the LEERINK conference and subsequent replay may be accessed by visiting Veracyte’s website at http://investor.veracyte.com. The webcast will be available shortly after conclusion of the presentation and archived on the company’s website for 90 days following the presentation.

About Veracyte
Veracyte (NASDAQ: VCYT) is a leading genomic diagnostics company that is fundamentally improving patient care by resolving diagnostic uncertainty with evidence that is trustworthy and actionable. The company’s products uniquely combine genomic technology, clinical science and machine learning to provide answers that give physicians and patients a clear path forward without risky, costly surgery that is often unnecessary. Since its founding in 2008, Veracyte has commercialized three genomic tests, which are transforming the diagnosis of thyroid cancer, lung cancer and idiopathic pulmonary fibrosis and collectively target a $2 billion market opportunity. Veracyte is based in South San Francisco, California. For more information, please visit www.veracyte.com and follow the company on Twitter (@veracyte).

Veracyte and the Veracyte logo are trademarks of Veracyte, Inc.

 

SOURCE Veracyte

Manufacturing Technician I, DG Growth Systems – Organogenesis – La Jolla, CA

February 2, 2017 – 3:23 am

0-1 year with a Biotech Program certificate from an accredited college. Follows established company rules, regulations and safety precautions, and maintains…From Organogenesis – Thu, 02 Feb 2017 11:23:07 GMT – View all La Jolla jobs